AQCA Study: Pre-PCI Virtual QFR for Planning PCI vs. Conventional Angiography

Several studies have used physiological assessment after a percutaneous coronary intervention (PCI) to improve clinical outcomes. However, results are not entirely conclusive. The limitations of using these physiological assessment methods are the need for extra measurements with increased procedure time, more radiation, and more contrast, which in turn leads to higher costs. 

Estudio AQVA: QFR virtual previo a la ATC para planificar angioplastia coronaria vs angiografía convencional

To counteract these limitations, several authors have proposed the use of virtual quantitative flow reserve (QFR) prior to PCI to plan the best strategy, allowing for the simulation of different therapeutic strategies and their corresponding results.

The aim of this multicenter, randomized study was to evaluate whether QFR-guided PCI is superior to angiography-guided PCI for optimal post-PCI QFR outcomes.

The primary endpoint (PEP) was the proportion of vessels with a final post-CTA QFR <0.90. The secondary endpoint (SEP) was the post-PCO QFR value, procedure duration, use of a contrast agent, number of stents, and stent length. Another secondary endpoint was cardiovascular death, incidence of acute myocardial infarction, and ischemia-guided revascularization of the treated vessel.

The study enrolled 300 patients, of whom 151 were randomized to QFR-guided PCI and 148 to angiography-guided PCI. Mean patient age was 70 years, and most subjects were men. The most frequent clinical presentation was chronic stable angina, followed by non-ST-segment elevation myocardial infarction (NSTEMI). The most treated artery was the anterior descending artery.

Read also: Deep Vein Arterialization: Have We Conquered “Non-Revascularizable” Critical Limb Ischemia?

The PEP was significantly more frequent in the angiography-guided PCI group, compared with the QFR-guided PCI group (p = 0.009). The main cause of suboptimal outcome in the angiography-guided group was underestimation of diseased segments outside the stents. There were no differences in the SEP in terms of procedure length, amount of contrast agent used, and radiation dose. However, the stent length and the number of stents were lower in the QFR-guided PCI group (p = 0.06; p = 0.08, respectively).

Conclusion

This study showed that QFR-guided PCI was superior to angiography-guided PCI to achieve an optimal physiological result after PCI, defined as post-PCI QFR ≥0.90. The QRF-based strategy changed operator planning in 25% of cases and was not linked to longer procedure times nor larger doses of contrast agent or radiation.

Dr. Andrés Rodríguez.
Member of the editorial board of SOLACI.org.

Original Title: QFR-Based Virtual PCI or Conventional Angiography to Guide PCI The AQVA Trial.

Reference: Simone Biscaglia, MD et al J Am Coll Cardiol Intv 2023.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

ACC 2026 | DKCRUSH VIII: IVUS or angiography to guide PCI in complex coronary bifurcations

Intracoronary imaging guidance has become an established recommended strategy in complex coronary lesions. In the specific setting of complex bifurcations, uncertainty remained regarding the...

ACC 2026 | OPTIMAL: IVUS Guidance in PCI of the Unprotected Left Main Coronary Artery

Percutaneous coronary intervention (PCI) is considered an equivalent alternative to coronary artery bypass surgery in patients with left main coronary artery (LMCA) stenosis and...

ACC 2026 | IVUS-CHIP Trial: Intravascular ultrasound–guided versus angiography-guided complex PCI

Optimization of percutaneous coronary intervention (PCI) in complex lesions remains a relevant clinical challenge. In this context, the IVUS-CHIP trial was designed to evaluate...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...